Enhancing its commitment to providing the most advanced treatment options for cancer patients through clinical trials, Rutgers Cancer Institute of New Jersey has named Sanjay Goel, MD, MS as director of its Phase I/Investigational Therapeutics Program. He is also a professor of medicine at Rutgers Robert Wood Johnson Medical School. Read more here.

How India Can Put the Spotlight Back on Neglected Tropical Diseases
A boost in research and development will be the first step toward the elimination of these diseases. CMC Alumni Priscilla Rupalli (Batch 1987) and Winsley Rose (Batch 1991) discuss the